CR1 and Alpha-thalassemia: To control for this, we checked for the presence of highly prevalent RBC polymorphisms in Papua New Guinea (alpha thalassemia, CR1 exon 22 polymorphism, and GYPC exon 3 deletion) in the reRBC samples used in this study.